RecruitingNCT06799858

Localization of Breast Cancer with the Sirius Pintuition Magnetic Seed

Localization of Breast Cancer with the Sirius Pintuition Magnetic Seed: a Pilot Study in the Czech Republic

Sponsor

Jan Žatecký

Enrollment

40 participants

Start Date

Apr 1, 2024

Study Type

OBSERVATIONAL

Conditions

Breast Cancer Surgery

Summary

A prospective pilot study in the Czech Republic examining the use of magnetic seed Sirius Pintuition for the localization of non-palpable malignant breast tumors and pathological lymph nodes.

Eligibility

Min Age: 18 YearsMax Age: 99 Years

Plain Language Summary

Simplified for easier understanding

This study evaluates the Sirius Pintuition magnetic seed — a tiny device placed into breast tissue before surgery to help surgeons precisely locate and remove a non-palpable (cannot be felt by hand) breast tumor or an abnormal lymph node. The study looks at how accurate and effective this magnetic localization method is. **You may be eligible if...** - You have been diagnosed with breast cancer confirmed by a core-cut biopsy - Your tumor or affected lymph node cannot be felt by hand (non-palpable) - You are having breast cancer surgery at the Silesian Hospital in Opava - A magnetic seed has been placed to mark your tumor or lymph node **You may NOT be eligible if...** - You decline to participate in the study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEBreast cancer localisation with magnetic seed Sirius Pintuition

Patients with histologically proven non-palpable breast cancer or with histologically proven pathological lymph node will be localised by a magnetic seed Sirius Pintuition.